Trodelvy® Reduces Risk of Disease Progression or Death by 38% Versus Chemotherapy as First ...

Gilead Sciences, Inc. (Nasdaq: GILD) today shared positive data from the Phase 3 ASCENT-03 study demonstrating a highly statistically significant and clinically meaningful improvement in ...

London became a global hub for phone theft. Here's what's behind it

About 80,000 phones were stolen in the British capital last year. The police are finally discovering where many of them went ...
CURE

HR+/HER2- Metastatic Breast Cancer Progression Improved With Sac-TMT

Sacituzumab tirumotecan (sac-TMT) significantly improved progression-free survival compared to chemotherapy in HR-positive, HER2-negative breast cancer patients. Sac-TMT reduced the risk of disease ...

London became a global hub for phone theft. Now we know why

A record 80,000 phones were stolen in the city last year, according to police, giving London an undesirable reputation as a ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) reduced the risk of disease recurrence or death ...

Positive results from the DESTINY-Breast05 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) demonstrated a highly statistically significant and clinically meaningful improvement in ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) followed by THP before surgery resulted in a ...

Positive results from the DESTINY-Breast11 Phase III trial showed ENHERTU ® (fam-trastuzumab deruxtecan-nxki) followed by paclitaxel, trastuzumab and pertuzumab (THP) in the neoadjuvant setting ...